These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7504989)
21. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827 [TBL] [Abstract][Full Text] [Related]
22. Failure of correlation between B7 expression and activation of interleukin-2-secreting T cells. Lombardi G; Sidhu S; Dodi T; Batchelor R; Lechler R Eur J Immunol; 1994 Mar; 24(3):523-30. PubMed ID: 7510233 [TBL] [Abstract][Full Text] [Related]
23. Direct helper T cell-induced B cell differentiation involves interaction between T cell antigen CD28 and B cell activation antigen B7. Damle NK; Linsley PS; Ledbetter JA Eur J Immunol; 1991 May; 21(5):1277-82. PubMed ID: 1645270 [TBL] [Abstract][Full Text] [Related]
24. Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis. Blotta MH; Marshall JD; DeKruyff RH; Umetsu DT J Immunol; 1996 May; 156(9):3133-40. PubMed ID: 8617933 [TBL] [Abstract][Full Text] [Related]
25. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells. Johnson-Léger C; Christenson JR; Holman M; Klaus GG J Immunol; 1998 Nov; 161(9):4618-26. PubMed ID: 9794390 [TBL] [Abstract][Full Text] [Related]
26. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. Lanier LL; O'Fallon S; Somoza C; Phillips JH; Linsley PS; Okumura K; Ito D; Azuma M J Immunol; 1995 Jan; 154(1):97-105. PubMed ID: 7527824 [TBL] [Abstract][Full Text] [Related]
27. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100 [TBL] [Abstract][Full Text] [Related]
28. IL-4-producing CD8+ T cell clones can provide B cell help. Cronin DC; Stack R; Fitch FW J Immunol; 1995 Apr; 154(7):3118-27. PubMed ID: 7897202 [TBL] [Abstract][Full Text] [Related]
29. B7-1-dependent co-stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells. Deeths MJ; Mescher MF Eur J Immunol; 1997 Mar; 27(3):598-608. PubMed ID: 9079798 [TBL] [Abstract][Full Text] [Related]
30. Costimulation of CD28- T lymphocytes by 4-1BB ligand. DeBenedette MA; Shahinian A; Mak TW; Watts TH J Immunol; 1997 Jan; 158(2):551-9. PubMed ID: 8992967 [TBL] [Abstract][Full Text] [Related]
31. Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival. Yin D; Zhang L; Wang R; Radvanyi L; Haudenschild C; Fang Q; Kehry MR; Shi Y J Immunol; 1999 Oct; 163(8):4328-34. PubMed ID: 10510372 [TBL] [Abstract][Full Text] [Related]
32. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Roy M; Aruffo A; Ledbetter J; Linsley P; Kehry M; Noelle R Eur J Immunol; 1995 Feb; 25(2):596-603. PubMed ID: 7533092 [TBL] [Abstract][Full Text] [Related]
33. Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response. Greenwald RJ; Lu P; Halvorson MJ; Zhou X; Chen S; Madden KB; Perrin PJ; Morris SC; Finkelman FD; Peach R; Linsley PS; Urban JF; Gause WC J Immunol; 1997 May; 158(9):4088-96. PubMed ID: 9126967 [TBL] [Abstract][Full Text] [Related]
34. Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity. Sad S; Krishnan L; Bleackley RC; Kägi D; Hengartner H; Mosmann TR Eur J Immunol; 1997 Apr; 27(4):914-22. PubMed ID: 9130644 [TBL] [Abstract][Full Text] [Related]
35. Human B7-1 is more efficient than B7-2 in providing co-stimulation for alloantigen-specific T cells. van Dijk AM; Otten HG; Vercauteren SM; Kessler FL; de Boer M; Verdonck LF; de Gast GC Eur J Immunol; 1996 Sep; 26(9):2275-8. PubMed ID: 8814278 [TBL] [Abstract][Full Text] [Related]
36. Functional characterization of a novel anti-B7 monoclonal antibody. de Boer M; Parren P; Dove J; Ossendorp F; van der Horst G; Reeder J Eur J Immunol; 1992 Dec; 22(12):3071-5. PubMed ID: 1280221 [TBL] [Abstract][Full Text] [Related]
37. Co-stimulation by anti-immunoglobulin is required for B cell activation by CD40Llow T cells. Poudrier J; Owens T Eur J Immunol; 1994 Dec; 24(12):2993-9. PubMed ID: 7805727 [TBL] [Abstract][Full Text] [Related]
38. Activated T cells can induce high levels of CTLA-4 expression on B cells. Kuiper HM; Brouwer M; Linsley PS; van Lier RA J Immunol; 1995 Aug; 155(4):1776-83. PubMed ID: 7543532 [TBL] [Abstract][Full Text] [Related]
39. Ligation of CD28 receptor by B7 induces formation of D-3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation. Ward SG; Westwick J; Hall ND; Sansom DM Eur J Immunol; 1993 Oct; 23(10):2572-7. PubMed ID: 8405057 [TBL] [Abstract][Full Text] [Related]
40. CD28 functions as an adhesion molecule and is involved in the regulation of human IgE synthesis. Life P; Aubry JP; Estoppey S; Schnuriger V; Bonnefoy JY Eur J Immunol; 1995 Feb; 25(2):333-9. PubMed ID: 7533083 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]